WO2023059047A1 - Composition pour la prévention ou le traitement de la chute des cheveux, comprenant un extrait de samdachal-jo (millet glutineux de jeju) - Google Patents
Composition pour la prévention ou le traitement de la chute des cheveux, comprenant un extrait de samdachal-jo (millet glutineux de jeju) Download PDFInfo
- Publication number
- WO2023059047A1 WO2023059047A1 PCT/KR2022/014951 KR2022014951W WO2023059047A1 WO 2023059047 A1 WO2023059047 A1 WO 2023059047A1 KR 2022014951 W KR2022014951 W KR 2022014951W WO 2023059047 A1 WO2023059047 A1 WO 2023059047A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- hair loss
- perilla
- samda
- dermal papilla
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 66
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 50
- 208000024963 hair loss Diseases 0.000 title claims abstract description 45
- 230000003676 hair loss Effects 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 244000062793 Sorghum vulgare Species 0.000 title abstract description 4
- 235000019713 millet Nutrition 0.000 title abstract description 4
- 230000002500 effect on skin Effects 0.000 claims abstract description 63
- 230000035755 proliferation Effects 0.000 claims abstract description 27
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 50
- 235000004347 Perilla Nutrition 0.000 claims description 49
- 239000000469 ethanolic extract Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 20
- 239000002021 butanolic extract Substances 0.000 claims description 17
- 230000002265 prevention Effects 0.000 claims description 15
- 238000011282 treatment Methods 0.000 claims description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 241000195493 Cryptophyta Species 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 230000003752 improving hair Effects 0.000 claims description 8
- 241000218645 Cedrus Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 230000006872 improvement Effects 0.000 claims description 5
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 235000020710 ginseng extract Nutrition 0.000 claims description 3
- 230000001965 increasing effect Effects 0.000 abstract description 19
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 45
- 230000000694 effects Effects 0.000 description 38
- 230000004663 cell proliferation Effects 0.000 description 27
- 210000004209 hair Anatomy 0.000 description 14
- 239000013641 positive control Substances 0.000 description 14
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 13
- 229960003632 minoxidil Drugs 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000002035 hexane extract Substances 0.000 description 10
- 239000002026 chloroform extract Substances 0.000 description 8
- 239000002024 ethyl acetate extract Substances 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000002062 proliferating effect Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000003779 hair growth Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000031774 hair cycle Effects 0.000 description 3
- 239000012454 non-polar solvent Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000003135 vibrissae Anatomy 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 235000007226 Setaria italica Nutrition 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 229960004199 dutasteride Drugs 0.000 description 2
- -1 etc.) Chemical compound 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940054749 avodart Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 239000004036 potassium channel stimulating agent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940117382 propecia Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940107889 rogaine Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 201000001297 telogen effluvium Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Definitions
- the present invention relates to a composition for preventing, treating, or improving hair loss comprising an extract of cedar algae.
- the present invention relates to a pharmaceutical composition or a food composition for preventing, treating, or improving hair loss by increasing the proliferation of dermal papilla cells, comprising an extract of Samdacha algae as an active ingredient.
- Dermal papilla cells are key cells responsible for the development and growth of hair, and are located at the bottom of the hair root, which is the root of the hair subcutaneously. In fact, when dermal papilla cells are collected from the scalp, cultured, and transplanted, new hair grows. However, there are several difficulties in using dermal papilla cells as a hair loss treatment. First, it is difficult to separate from the scalp, the culture conditions are difficult, and it is difficult to culture a sufficient amount of cells. In addition, when cultured a lot, there is a limit in that the hair regeneration ability is significantly lowered.
- Finasteride and dutasteride are 5 ⁇ -reductase inhibitors that inhibit the conversion of testosterone to 5 ⁇ -dihydrotestosterone (DHT).
- DHT 5 ⁇ -dihydrotestosterone
- Samdachajo is a native Jeju region, and is a kind of grain of millet ( Setaria italica ).
- Korean Patent Registration No. 10-2150927 discloses the anti-inflammatory effect, skin moisturizing effect, skin barrier strengthening effect, and atopy improving effect of the mixed extract of Samda algae, the effect of improving hair loss of the Samda alga extract is not disclosed at all.
- the inventors of the present invention completed the present invention by discovering that the Samda perilla extract has an effect of proliferating dermal papilla cells in the process of researching a substance having excellent preventive and therapeutic effects on hair loss with few side effects.
- Patent Document 1 Korean Patent Registration No. 10-2150927
- An object of the present invention is to provide a pharmaceutical composition for the prevention or treatment of hair loss containing an extract of cedar algae.
- an object of the present invention is to provide a food composition for the prevention or improvement of hair loss containing the extract of cedar algae.
- the present invention provides a pharmaceutical composition for the prevention or treatment of hair loss containing the extract of cedar algae.
- the present invention provides a food composition for the prevention or improvement of hair loss containing the extract of Samdachajo.
- the Samdachajo extract may be extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, ethyl acetate, hexane, chloroform, and mixed solvents thereof, but is not limited thereto.
- the Samda perilla extract of the present invention may be 0.01% to 90% ethanol extract or butanol extract, more preferably, the Samda perilla extract of the present invention may be 60% to 80% ethanol extract or butanol extract, and most preferably Preferably, the extract of Samdachajo of the present invention may be a 70% ethanol extract or a butanol extract.
- the extract of Samdachajo of the present invention can prevent, treat, or improve hair loss by increasing the proliferation of dermal papilla cells.
- composition containing the extract of Samdacha algae of the present invention as an active ingredient promotes the proliferation of dermal papilla cells to induce the growth phase of hair, while having few side effects, so it can be effectively used to improve hair growth or hair loss.
- Figure 1 shows the results of measuring the proliferation effect of dermal papilla cells for 70% ethanol extract of Samda perilla.
- Figure 2 shows the results of measuring the proliferation effect of dermal papilla cells for the hexane extract of Samdachajo.
- Figure 3 shows the results of measuring the proliferation effect of dermal papilla cells for the ethyl acetate extract of Samda perilla.
- Figure 4 shows the results of measuring the proliferation effect of dermal papilla cells for the chloroform extract of Samda perilla.
- Figure 5 shows the results of measuring the proliferation effect of dermal papilla cells for the butanol extract of Samda perilla.
- Figure 6 shows the results of measuring the proliferation effect of dermal papilla cells on the hot water extract of Samdachajo.
- Figure 7 shows the results of measuring the proliferation effect of dermal papilla cells for the perilla 70% ethanol extract.
- Figure 8 shows the results of measuring the proliferation effect of dermal papilla cells on the perilla hot water extract.
- the present invention relates to a pharmaceutical composition for the prevention or treatment of hair loss comprising an extract of cedar algae.
- Air loss refers to a condition in which there is no hair in an area where hair should normally exist, regardless of the cause, and includes circular alopecia, hereditary androgenetic alopecia, telogen effluvium, traumatic alopecia, hair growth, pressure alopecia, It may be anagen hair loss, pityroid hair loss, syphilitic hair loss, seborrheic hair loss, symptomatic hair loss, scarring hair loss or congenital hair loss, but is not limited thereto.
- Samda chajo Setaria italica Beauv.
- Samda tea which is harvested from Jeju Island, but is not limited thereto.
- the ginseng extract of the present invention can exhibit the effect of preventing or treating hair loss by promoting the proliferation of dermal papilla cells and inducing the growth phase of hair.
- Treatment of the present invention is to improve the symptoms of hair loss by delaying or stopping the progress of hair loss by administering the composition of the present invention, or beneficially changing the symptoms of hair loss, such as promoting hair growth and hair growth, such as lengthening or increasing the number of hairs. means all actions
- Prevention of the present invention refers to any action that suppresses or delays the onset of hair loss by administration of the composition according to the present invention, and “improvement” is related to the condition treated by administration of the composition containing the extract of the present invention. Any action that at least reduces the severity of a parameter, eg a symptom.
- the "extract" of the present invention can be obtained using a conventional extraction solvent known in the art.
- a polar solvent or a non-polar solvent may be used as the extraction solvent.
- Polar solvents include water, C1 to C6 alcohols (eg, methanol, ethanol, propanol, butanol, n-propanol, iso-propanol and n-butanol, etc.), acetic acid, or mixtures of the above polar solvents.
- Non-polar solvents include acetone, acetonitrile, ethyl acetate, methyl acetate, butyl acetate, fluoroalkanes, hexane, ether, chloroform, dichloromethane or mixtures of the above non-polar solvents.
- the extract may be extracted with a solvent selected from the group consisting of water, C1 to C6 alcohol, acetic acid, and a mixed solvent thereof.
- a solvent selected from the group consisting of water, C1 to C6 alcohol, acetic acid, and a mixed solvent thereof.
- it is 0.01% to 90% ethanol extract or butanol extract, more preferably 60% to 80% ethanol extract or butanol extract, and most preferably 70% ethanol extract or butanol extract.
- the extract of the present invention may be extracted through hot water extraction, cold extraction, reflux cooling extraction, ultrasonic extraction, or a conventional extraction method known in the art.
- extract used in the present invention means what is commonly used as a crude extract in the art, but also includes a fraction obtained by additional fractionation of the extract in a broad sense. That is, the extract includes not only those obtained using the above-described solvent, but also those obtained by additionally applying a purification process thereto. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a certain molecular weight cut-off value, separation by various chromatographs (designed for separation according to size, charge, hydrophobicity or affinity), etc. Fractions obtained through the purification method are also included in the crude drug extract of the present invention.
- the pharmaceutical composition of the present invention can be parenterally administered or orally administered according to the desired method, and the dosage depends on the patient's weight, age, sex, health condition, diet, administration time, administration method, excretion rate, and severity of the disease. Its range is diverse.
- the therapeutically effective amount of the composition may vary depending on the administration method, the target site, and the condition of the patient, and when used in the human body, the dosage should be determined in an appropriate amount in consideration of safety and efficiency.
- the present invention relates to a food composition for preventing or improving hair loss comprising a samdachajo composition.
- the food composition may be a health functional food, dairy product, fermented product or food additive.
- the “health functional food” refers to food manufactured and processed using raw materials or ingredients having useful functionalities for the human body, and “functional” refers to health uses such as adjusting nutrients for the structure and function of the human body or physiological actions, etc. It means to take it for the purpose of obtaining a beneficial effect on it.
- the food composition is various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and enhancers (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and It may further include salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohol, carbonation agents used in carbonated beverages, and the like.
- the food composition includes a form such as a pill, powder, granule, precipitate, tablet, capsule, liquid, paste, gel, or jelly, and the food to which the composition can be added includes, for example, There are various types of foods, such as beverages, chewing gum, tea, vitamin complexes, health supplements, and the like.
- the formulation of the food composition is not particularly limited, but may be formulated into, for example, tablets, granules, powders, liquids such as drinks, caramels, gels, bars, and the like.
- the food composition of each formulation can be formulated without difficulty by a person skilled in the art according to the formulation or purpose of use by selecting and blending ingredients commonly used in the field in addition to the active ingredient.
- Samda-chajo 70% ethanol extract Samda-chajo hot water extract, Samda-chajo hexane extract, Samda-chajo ethyl acetate extract, Samda-chajo chloroform extract, Samda-chajo butanol extract, Samda-chajo 70% ethanol extract, and Samda-chajo hot-water extract were prepared.
- Proliferation of rat vibrissa immortalized dermal papilla cells immortalized from dermal papilla cells isolated from rat whiskers was measured using the MTT assay.
- Dermal papilla cells (1.0 ⁇ 10 4 cells/mL) were turbid in DMEM medium containing 1% FBS, placed in a 96 well plate, and cultured for 24 hours.
- Samdachajo 70% ethanol extract was treated at concentrations of 1, 10 and 25 ⁇ g/mL.
- minoxidil Sigma, MO, USA
- 10 ⁇ M concentration 10 ⁇ M concentration.
- WST dye Daeil Lab Service, Seoul, Korea
- Absorbance was measured at 450 nm using a VERSAmax microplate reader (Molecular Devices, CA, USA). The average absorbance value for the sample group was obtained, and the degree of proliferation was investigated in comparison with the absorbance value of the control group, and is shown in Table 1 and FIG. 1 below.
- the 70% ethanol extract of Samdachajo has a dermal papilla cell proliferation effect.
- control group - 100.0 minoxidil (positive control) 10 ⁇ M 109.1 Samda tea hexane extract 1 ⁇ g/mL 100.3 ⁇ 6.1
- the hexane extract of Samdachajo has the dermal papilla cell proliferation effect.
- Example 3 In the same manner as in Example 3, an experiment was performed on the dermal papilla cell proliferation effect of the extract of Samda perilla ethyl acetate, and the results are shown in Table 3 and FIG. 3 below.
- the ethyl acetate extract of Samdachajo has a dermal papilla cell proliferation effect.
- the chloroform extract of Samda perilla has the dermal papilla cell proliferation effect.
- the butanol extract of Samdachajo has the dermal papilla cell proliferation effect.
- Example 3 In the same manner as in Example 3, an experiment was performed on the dermal papilla cell proliferation effect of the hot water extract of Samdacha algae, and the results are shown in Table 6 and FIG. 6 below.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La présente invention concerne une composition pour prévenir, traiter ou atténuer une perte de cheveux, comprenant un extrait de Samdachal-jo (millet glutineux de Jeju). En particulier, la présente invention concerne une composition pharmaceutique ou une composition alimentaire pour prévenir, traiter ou atténuer la perte de cheveux par l'augmentation de la prolifération de cellules de papille dermique, la composition comprenant un extrait de Samdachal-jo en tant que principe actif.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2021-0134050 | 2021-10-08 | ||
KR1020210134050A KR102684917B1 (ko) | 2021-10-08 | 삼다차조 추출물을 포함하는 탈모의 예방 또는 치료를 위한 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023059047A1 true WO2023059047A1 (fr) | 2023-04-13 |
Family
ID=85803610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/014951 WO2023059047A1 (fr) | 2021-10-08 | 2022-10-05 | Composition pour la prévention ou le traitement de la chute des cheveux, comprenant un extrait de samdachal-jo (millet glutineux de jeju) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023059047A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008520588A (ja) * | 2004-11-18 | 2008-06-19 | ビオファーマコペ デジン アンテルナショナル インク. | 植物抽出物およびその皮膚科使用法 |
KR20190037777A (ko) * | 2017-09-29 | 2019-04-08 | 유씨엘 주식회사 | 두피염증 예방 및 완화, 및 탈모방지 효과가 있는 화장료 조성물 |
KR20200091361A (ko) * | 2019-01-22 | 2020-07-30 | 이동완 | 오이, 가지 및 달팽이의 혼합 추출물을 유효성분으로 포함하는 탈모 방지 또는 발모 촉진용 조성물 |
KR20210012169A (ko) * | 2019-07-24 | 2021-02-03 | 주식회사 바이오원코리아 | 식물 생약재를 포함하는 탈모 예방 및 발모용 식품 조성물 및 그 제조방법 |
-
2022
- 2022-10-05 WO PCT/KR2022/014951 patent/WO2023059047A1/fr unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008520588A (ja) * | 2004-11-18 | 2008-06-19 | ビオファーマコペ デジン アンテルナショナル インク. | 植物抽出物およびその皮膚科使用法 |
KR20190037777A (ko) * | 2017-09-29 | 2019-04-08 | 유씨엘 주식회사 | 두피염증 예방 및 완화, 및 탈모방지 효과가 있는 화장료 조성물 |
KR20200091361A (ko) * | 2019-01-22 | 2020-07-30 | 이동완 | 오이, 가지 및 달팽이의 혼합 추출물을 유효성분으로 포함하는 탈모 방지 또는 발모 촉진용 조성물 |
KR20210012169A (ko) * | 2019-07-24 | 2021-02-03 | 주식회사 바이오원코리아 | 식물 생약재를 포함하는 탈모 예방 및 발모용 식품 조성물 및 그 제조방법 |
Non-Patent Citations (1)
Title |
---|
RAON: "The Grains of Raon - Types and Effects of Setaria italica Beauv. 라온의 곡류 – 차조의 종류 및 효능", NAVER BLOG, 29 March 2021 (2021-03-29), Retrieved from the Internet <URL:https://blog.naver.com/laonwhoje/222291307403> * |
Also Published As
Publication number | Publication date |
---|---|
KR20230050806A (ko) | 2023-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010134756A2 (fr) | Composition contenant un extrait de thé vert | |
WO2015137652A1 (fr) | Huile de graines fermentées de camellia japonica inhibant la 5-alpha réductase permettant d'atténuer une hypertrophie bénigne de la prostate et la calvitie | |
WO2015002391A1 (fr) | Composition présentant une fonction d'atténuation du syndrome prémenstruel et des douleurs menstruelles | |
WO2014058142A1 (fr) | Composition pharmaceutique contenant un extrait d'aster glehni en tant que principe actif pour la prévention et le traitement de l'obésité et de troubles métaboliques | |
WO2018105926A1 (fr) | Composition anti-allergique contenant un extrait d'herbe médicinale composite fermenté par des lactobacilles à titre de principe actif | |
WO2018117725A1 (fr) | Composition pour prévenir la chute des cheveux et favoriser la pousse des cheveux, comprenant des produits animaux marins fermentés | |
WO2015108394A1 (fr) | Composition cosmétique contenant un composé dérivé de l'hydroxypyranone pour stimuler la différenciation des adipocytes | |
WO2018043874A1 (fr) | Composition permettant de prévenir la chute des cheveux ou de favoriser la pousse des cheveux, comprenant des souches présentant un effet de lipolyse | |
WO2020040432A1 (fr) | Composition pharmaceutique pour prévenir ou traiter des maladies musculaires, contenant un extrait de baie de ginseng en tant que principe actif | |
WO2016056781A1 (fr) | Composition pour prévenir la chute des cheveux ou stimuler la pousse des cheveux comprenant un extrait d'artemisia umbelliformis | |
WO2023059047A1 (fr) | Composition pour la prévention ou le traitement de la chute des cheveux, comprenant un extrait de samdachal-jo (millet glutineux de jeju) | |
WO2023022540A1 (fr) | Composition de prévention de la perte de cheveux ou favorisant la pousse des cheveux comprenant un extrait de fleur de chardon-marie comme ingrédient actif | |
WO2016056780A1 (fr) | Composition pour prévenir la chute des cheveux ou stimuler la pousse des cheveux comprenant un extrait de scutellaria alpina | |
WO2013115456A1 (fr) | Aliment, substance cosmétique, ou composition pharmaceutique contenant un extrait supercritique de gingembre et un extrait de résidu de persil japonais fermenté | |
WO2019139403A1 (fr) | Composition contenant de la séricine, un extrait de torilis japonica et un extrait de viscum album pour la régénération de la peau, l'apaisement de la peau ou la cicatrisation des plaies | |
WO2023038258A1 (fr) | Nouvelle souche lactobacillus gasseri lm1065 issue du lait maternel, et composition pour soulager le syndrome prémenstruel comprenant ladite souche ou son produit de culture | |
WO2021215882A1 (fr) | Composition pour prévenir la chute des cheveux ou favoriser la pousse des cheveux comprenant un extrait de péricarpe de camélia en tant que principe actif | |
WO2014133276A1 (fr) | Composition contenant, en tant que composants actifs, menispermum dauricum, un extrait de menispermum dauricum, un biofilm de menispermum dauricum, ou un extrait de liquide enzymatique de malt de menispermum dauricum pour prévenir ou traiter l'anorexie | |
WO2023059053A1 (fr) | Composition pour prévenir ou soulager la perte de cheveux, comprenant un extrait de sétaire d'italie glutineux samda | |
KR101273027B1 (ko) | 캄페롤을 유효성분으로 함유하는 피지 분비 억제용 및항비만용 조성물 | |
WO2016003120A1 (fr) | Composition de blanchiment comprenant un extrait de scutellaria alpina | |
WO2019164090A1 (fr) | Composition contenant un extrait de symplocarpe fétide ou une fraction de celui-ci utilisé comme principe actif pour l'atténuation des rides | |
KR102684917B1 (ko) | 삼다차조 추출물을 포함하는 탈모의 예방 또는 치료를 위한 조성물 | |
WO2015152653A1 (fr) | Composition comprenant un extrait de feuilles de génépi blanc | |
WO2024014663A1 (fr) | Composition pharmaceutique destinée à prévenir ou à traiter l'alopécie comprenant de l'akkermansia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22878868 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |